IRIS
Aliberti, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.570
AS - Asia 8.475
EU - Europa 2.267
SA - Sud America 1.509
Continente sconosciuto - Info sul continente non disponibili 497
AF - Africa 162
OC - Oceania 25
Totale 25.505
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.197
SG - Singapore 5.196
CN - Cina 1.545
BR - Brasile 1.241
VN - Vietnam 733
IT - Italia 666
IE - Irlanda 347
FI - Finlandia 277
DE - Germania 276
HK - Hong Kong 268
GB - Regno Unito 202
CA - Canada 166
IN - India 152
BD - Bangladesh 112
AR - Argentina 107
MX - Messico 88
FR - Francia 80
RU - Federazione Russa 73
IQ - Iraq 66
ES - Italia 54
SE - Svezia 54
EC - Ecuador 51
PL - Polonia 51
ID - Indonesia 50
JP - Giappone 45
TR - Turchia 44
ZA - Sudafrica 40
PH - Filippine 34
PK - Pakistan 34
NL - Olanda 29
CO - Colombia 27
CZ - Repubblica Ceca 27
UA - Ucraina 25
MY - Malesia 24
SA - Arabia Saudita 24
MA - Marocco 21
VE - Venezuela 21
AU - Australia 20
CR - Costa Rica 20
NG - Nigeria 20
UZ - Uzbekistan 20
EG - Egitto 19
AE - Emirati Arabi Uniti 18
LT - Lituania 17
PE - Perù 17
HN - Honduras 15
NP - Nepal 14
TT - Trinidad e Tobago 14
CL - Cile 13
JM - Giamaica 13
JO - Giordania 13
KE - Kenya 13
UY - Uruguay 13
PT - Portogallo 12
TN - Tunisia 12
DO - Repubblica Dominicana 11
NI - Nicaragua 11
AZ - Azerbaigian 10
DZ - Algeria 10
IL - Israele 10
GT - Guatemala 9
PY - Paraguay 9
BO - Bolivia 8
AT - Austria 7
EE - Estonia 7
RS - Serbia 7
AL - Albania 6
BH - Bahrain 6
CI - Costa d'Avorio 6
ET - Etiopia 6
KG - Kirghizistan 6
KR - Corea 6
OM - Oman 6
PA - Panama 6
PR - Porto Rico 6
AO - Angola 5
HU - Ungheria 5
KZ - Kazakistan 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
BE - Belgio 4
BG - Bulgaria 4
BY - Bielorussia 4
DK - Danimarca 4
KW - Kuwait 4
RO - Romania 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
GE - Georgia 3
GR - Grecia 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
QA - Qatar 3
SV - El Salvador 3
TW - Taiwan 3
CH - Svizzera 2
DM - Dominica 2
HR - Croazia 2
LB - Libano 2
Totale 24.973
Salva come PNG Salva come JPEG
Città #
Singapore 2.118
San Jose 1.789
Ashburn 1.758
Dallas 1.379
The Dalles 828
Shanghai 702
New York 553
Council Bluffs 516
Boardman 463
Dublin 345
Los Angeles 336
Santa Clara 310
Beijing 300
Helsinki 275
Hong Kong 255
Ho Chi Minh City 236
Milan 178
Hanoi 169
Phoenix 139
Falkenstein 123
Buffalo 113
São Paulo 104
Seattle 94
Rome 68
Chicago 66
London 65
Naples 60
Charlotte 59
Atlanta 52
Montreal 52
Assago 50
Da Nang 50
Chandler 49
Orem 47
Warsaw 47
Brooklyn 45
Moscow 42
Princeton 42
Rio de Janeiro 39
Chennai 38
Boston 36
Tokyo 34
Houston 33
Brasília 31
Toronto 31
Johannesburg 30
Mexico City 30
Philadelphia 29
Denver 28
Wilmington 28
Dhaka 27
Haiphong 27
Miami 27
San Francisco 26
Curitiba 24
Belo Horizonte 23
Milwaukee 22
Stockholm 22
Baghdad 21
Cleveland 21
Frankfurt am Main 21
Manchester 21
Pasadena 21
Abbeville 20
The Bronx 20
Benin City 18
Guayaquil 18
Tashkent 18
Brno 17
Las Vegas 17
Turin 17
Queens 16
Sydney 16
Ankara 15
Pittsburgh 15
Pune 15
Campinas 14
Guarulhos 14
Hangzhou 14
Munich 14
Paris 14
Quito 14
San José 14
Columbus 13
Chengdu 12
Erbil 12
Florence 12
Fortaleza 12
Kansas City 12
Nairobi 12
Salvador 12
Washington 12
Amsterdam 11
Aurora 11
Baltimore 11
Kuala Lumpur 11
Lawrence 11
Lima 11
Montevideo 11
Mumbai 11
Totale 15.084
Salva come PNG Salva come JPEG
Nome #
100 years of respiratory medicine : Pneumonia 653
COVID-19 Vaccination Still Makes Sense: Insights on Pneumonia Risk and Hospitalization from a Large-Scale Study at an Academic Tertiary Center in Italy 391
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 150
Diagnosis and management of patients with alpha 1-antitrypsin deficiency: an Italian perspective 140
Mapping the human genetic architecture of COVID-19 128
Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia 123
COVID-19 in Immunocompromised Patients: A Systematic Review 120
Cardiovascular Complications in Community-Acquired Pneumonia 113
Treatable traits in interstitial lung diseases: a call to action 106
A comprehensive approach to lung function in bronchiectasis 106
Community-acquired pneumonia 104
A comprehensive analysis of the impact of pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis 104
A systematic review of the effect of delayed appropriate antibiotic treatment on the outcomes of patients with severe bacterial infections 99
A 13-year-old female with shortness of breath and pleuritic chest pain 96
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study 96
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 96
A Cluster Analysis of Bronchiectasis Patients Based on the Airway Immune Profile 95
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 95
A pathway to keep all lifelong learners up to date: The ERS continuing professional development programme 94
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation 91
Diagnosis and Initial Investigation of Bronchiectasis 89
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 89
Epidemiology and Resistance Profiles of Bacteria Isolated From Blood Samples in Septic Patients at Emergency Department Admission: A 6-Year Single Centre Retrospective Analysis From Northern Italy 87
COVID-19 in lung transplant recipients: A case series from Milan, Italy 86
Williams-Campbell Syndrome Case Series and Discordant Twins 86
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults 85
Identifying risk factors and pathogens in postoperative pneumonia after lung surgery for cancer: a retrospective cohort study 85
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients 85
Quando ospedalizzare un paziente con polmonite acquisita in comunità 85
Maternal and fetal outcomes in multiparous women with Cystic Fibrosis 85
Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry 84
Detection and Classification of Bronchiectasis Through Convolutional Neural Networks 83
COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemia 81
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 81
Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review 80
A 61-year-old female with chronic cough and purulent sputum 80
COVID-19 multidisciplinary high dependency unit: the Milan model 80
An extensive bundle of tests is needed to detect treatable causes of bronchiectasis (Bx) 80
A real life evaluation of non invasive ventilation in acute cardiogenic pulmonary edema: a multicenter, perspective, observational study for the ACPE SIMEU study group 79
A New SERPINA-1 Missense Mutation Associated with Alpha-1 Antitrypsin Deficiency and Bronchiectasis 78
Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis 78
Acidemia does not affect outcomes of patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure 77
Post-COVID-19 sequelae 77
Lung Ultrasound in the Diagnosis and Follow-up of Community-Acquired Pneumonia : A Prospective, Multicenter, Diagnostic Accuracy Study 77
SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity 77
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia 77
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 77
A DELAY IN REACHING TIME TO CLINICAL STABLITY FOR HOSPITALISED PATIENTS WITH CAP IS ASSOCIATED WITH FAILURE WITHIN 30 DAYS AFTER HOSPITAL DISCHARGE 76
Cardiovascular side-effects of common antibiotics 76
Overweight and obesity in adults with cystic fibrosis: An Italian multicenter cohort study 75
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review 75
What is the best technique to extract bacterial DNA from sputum? 75
Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia 75
Comparison of different conditions for DNA extraction in sputum - a pilot study 74
Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia 74
Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience 74
A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia 74
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 74
Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia 74
Long-Term Outcomes in Severe Community-Acquired Pneumonia 73
A patient-tailored approach for corticosteroid treatment in COVID-19: still not there yet 73
In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm 73
A worldwide look into long COVID-19 management: an END-COVID survey 72
18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infectionsA case series on the use of Nuclear Medicine in NTM-PD 72
Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC) 72
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 72
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 72
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 71
Risk Factors for Noninvasive Ventilation Failure in Critically Ill Subjects With Confirmed Influenza Infection 71
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 71
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review 70
How to Identify Causes and Predisposing Factors in Bronchiectasis 69
Protease-Antiprotease Imbalance in Bronchiectasis 69
Dysregulation of the microbial ‘gut-lung’ axis in bronchiectasis 69
Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients 69
Towards tuberculosis elimination: an action framework for low-incidence countries 68
Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disorders 68
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 68
ERS/ECDC statement : European Union standards for tuberculosis care, 2017 update 67
Antimicrobial peptides, disease severity and exacerbations in bronchiectasis 67
Acute effects of positive end-expiratory pressure on left ventricle diastolic function in healthy subjects 67
Bronchiectasis and Aspergillus: how are they linked? 67
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience 67
Integrative microbiomics in bronchiectasis exacerbations 66
Site of care and multidisciplinary approach 66
Structural Lung Disease and Clinical Phenotype in Bronchiectasis Patients: The EMBARC CT Study 66
Antibiotics for lung disease and cancer 66
T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis 66
First Report of the Prevalence at Baseline and after 1-Year Follow-Up of Treatable Traits in Interstitial Lung Diseases 66
The Relationship Between Symptoms, Exacerbations and Treatment Response in Bronchiectasis 65
Neutrophil elastase in bronchiectasis 65
A multicenter randomised control trial to evealuate CPAP versus conventional oxygen in patients with acute respiratory failure (ARF) due to CAP 65
Chlamydia pneumoniae and acute aortic syndrome : a call for a multi-institutional study 65
Management of hospitalised adults with coronavirus disease-19 (COVID-19): A European Respiratory Society living guideline 64
Walking the path of treatable traits in interstitial lung diseases 64
O papel da neutropenia no prognóstico do doente oncológico com pneumonia adquirida na comunidade = The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia 64
Respiratory failure in COVID-19: a patient's perspective and clinical cases 64
The effectiveness of the polysaccharide pneumococcal vaccine for theprevention of hospitalizations due to Streptococcus pneumoniaecommunity-acquired pneumonia in the elderly differs between thesexes : results from the Community-Acquired PneumoniaOrganization (CAPO) international cohort study 64
Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia 64
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 64
Totale 8.885
Salva come PNG Salva come JPEG
Categoria #
all - tutte 151.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.607
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202257 0 0 0 4 0 0 0 3 8 20 17 5
2022/2023595 25 8 19 9 16 5 55 14 43 65 322 14
2023/20243.347 221 157 794 191 171 607 220 92 39 143 295 417
2024/20254.305 119 23 40 88 100 515 237 236 938 1.117 455 437
2025/202613.049 1.773 857 1.264 956 432 686 3.569 576 620 854 534 928
2026/20274.105 568 799 2.175 563 0 0 0 0 0 0 0 0
Totale 25.505